Stay updated on M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial

Sign up to get notified when there's something new on the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Core study details and primary actions appear unchanged. Any observed differences seem limited to formatting or minor wording edits.
    Difference
    0.4%
    Check dated 2025-11-03T13:10:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.
    Difference
    4%
    Check dated 2025-10-06T01:47:08.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page has shifted from broad solution/pharmaceutical categories to a more detailed chemical- and compound-focused taxonomy, with an updated version tag (v3.1.0).
    Difference
    1.0%
    Check dated 2025-09-28T23:25:07.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:48:58.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T07:46:11.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, as well as new pharmaceutical preparations related to H1N1 Flu. However, several location-related terms and previous vaccine information have been removed.
    Difference
    2%
    Check dated 2025-08-31T00:56:18.000Z thumbnail image

Stay in the know with updates to M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page.